Zoetis Inc. (LON: 0M3Q)
London flag London · Delayed Price · Currency is GBP · Price in USD
163.15
-1.99 (-1.21%)
Dec 23, 2024, 5:40 PM BST

Zoetis Company Description

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally.

The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives.

In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health.

It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health.

Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Zoetis Inc.
Country United States
Founded 1952
Industry Medical - Pharmaceuticals
Sector Healthcare
Employees 14,100
CEO Kristin Peck

Contact Details

Address:
10 Sylvan Way
Parsippany, Delaware 07054
United States
Phone 973 822 7000
Website zoetis.com

Stock Details

Ticker Symbol 0M3Q
Exchange London Stock Exchange
Fiscal Year January - December
Reporting Currency USD
ISIN Number US98978V1035
SIC Code 2834

Key Executives

Name Position
Kristin C. Peck Chief Executive Officer and Director
Wafaa Mamilli Executive Vice President and Group President for China, Brazil and Preci. Animal Health
Dr. Robert J. Polzer Ph.D. Executive Vice President and President of Research and Development
Keith Sarbaugh Executive Vice President and Chief Digital and Technology Officer
Steven Frank Vice President of Investor Relations
Roxanne Lagano Executive Vice President, General Counsel and Corporate Secretary
William Price Vice President and Chief Communications Officer
Julie A. Fuller Executive Vice President, Chief Human Resources Officer and Global Operations
Jeannette Ferran Astorga Executive Vice President of Corporate Affairs and Communications and Chief Sustainability Officer
Nick Ashton Executive Vice President and President of Global Manufacturing and Supply